Corporate, or "strategic," investors are busy making digital health investments in smaller companies as they seek to fortify their presence in that important space. So far 2014 boasts about 70 deals worth $800 million, easily exceeding last year's total. Deal volume is nearly double that of 2012. Since 2010 strategic players have made 210 deals totaling $2.34 billion. Qualcomm Ventures is the largest strategic investor, followed by Merck Global Health Innovation fund, BlueCross BlueShield Venture Partners and and Google Ventures. Other strategics in digital health: Intel ($INTC), Johnson & Johnson ($JNJ), Dignity Health, Kaiser Permanente, Reed Elsevier and General Electric ($GE). More